-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
August 05, 2010 - Are they being proposed as replacement, triage, or add-on tests?
d. … to (english language and humans)
8. exp "sensitivity and specificity"/
9. exp Predictive Value of Tests … For comparative studies of diagnostic
tests, we will extract details on the comparators of positional
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0320_06-17-2009.pdf
January 01, 2009 - Some experts agree that urine
tests are no longer necessary as part of the initial screening algorithm
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/renal-mass-and-localized-renal-cancer-the-following-questions-are-recommended-to-address-the-healthcare-tests-andor-treatments-this-program-should-consider-what-indicators-can-be-used-to-predict-malignancy-andor-aggressivene
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research.pdf
April 15, 2019 - The initial pilot tests revealed a lack of sensitivity. … +for+Multiple+Myeloma&CALId=131&CalName=Prothrombin+Time+(PT)+and+Partial+Thromboplastin+Time+(PTT)+tests … +for+Multiple+Myeloma&CALId=131&CalName=Prothrombin+Time+(PT)+and+Partial+Thromboplastin+Time+(PTT)+tests … +for+Multiple+Myeloma&CALId=131&CalName=Prothrombin+Time+(PT)+and+Partial+Thromboplastin+Time+(PTT)+tests … +for+Multiple+Myeloma&CALId=131&CalName=Prothrombin+Time+(PT)+and+Partial+Thromboplastin+Time+(PTT)+tests
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1506.pdf
June 01, 2015 - AHRQ is interested in innovations
in drugs and biologics, medical devices, screening and diagnostic tests … pertains to identification of new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
June 01, 2014 - AHRQ is interested in innovations in drugs and biologics, medical devices, screening and
diagnostic tests … to identification of new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
June 01, 2013 - AHRQ is interested in innovations in drugs and biologics, medical devices, screening and
diagnostic tests … pertains to identifying new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests
-
effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
January 01, 2012 - AHRQ is interested in innovations in drugs and biologics, medical devices, screening and
diagnostic tests … pertains to identifying new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-3.pdf
February 01, 2018 - On tests of the overall treatment effect in meta‐analysis with normally distributed responses. … On tests of the overall treatment effect in meta‐analysis with normally distributed responses.
-
effectivehealthcare.ahrq.gov/products/open-meta-analyst/abstract
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
September 14, 2016 - nonspecific bronchial hyperreactivity as
measured by response to methacholine or acetylcholine challenge tests … testing based on allergen
specific IgE sensitization diagnosis: Serologic multiallergen screen IgE tests … (skin
prick tests, serum tests, or both)
o Patients with all severity grades and control status of … proteins that act as
intercellular mediators) will not be included as outcomes.
3.- Objective Tests
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
January 01, 2010 - What is the analytic validity (sensitivity, specificity, reproducibility, reliability) of tests
designed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis-future_research_1.pdf
February 01, 2013 - CAD in the included population, our analyses again demonstrated
differences between performance of tests … appropriate use of NIT in women compared with men, the influence on
downstream testing (either multiple tests … March 13, 2012
Number of articles: 159
((((/diagnosis OR diagnos* OR predict* OR predictive value of tests … March 26, 2012
Number of articles: 66
((((/diagnosis OR diagnos* OR predict* OR predictive value of tests … female OR females OR sex factors
AND
A-9
diagnosis OR diagnos* OR predict* OR predictive value of tests
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-research-protocol.pdf
April 11, 2018 - Mortality;
o Quality of life;
o Hospital admission;
o ICU admission;
o Physical capacity (timed walking tests … , endurance tests)
o Number of intubations
KQ 1, 2,3 & 4: Adverse effects of interventions (harms … • Quality of life;
• Hospital admission;
• ICU admission;
• Physical capacity
(timed walking tests … ,
endurance tests)
• Number of intubations
None
Timing All None
Settings Outpatient, hospital … will evaluate potential publication bias by evaluating funnel plots symmetry and using
statistical tests
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
December 01, 2015 - AHRQ is interested in innovations
in drugs and biologics, medical devices, screening and diagnostic tests … to identification of new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests … Five percent of point-of-care Xpert MTB/RIF tests failed
compared with 6% of laboratory-run Xpert MTB … /RIF tests (p=0.22). … Updated guidelines for the use of nucleic acid
amplification tests in the diagnosis of
tuberculosis
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-5.pdf
February 01, 2018 - ://dx.doi.org/10.1016/j.jclinepi.2008.04.012
Single measures for consistency
• Global Wald test: Tests … ► Limitations include the need for multiple correlated tests.
• Side-splitting: A node is a treatment … • Statistical tests for inconsistency are commonly under-powered due to
limited number of studies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
September 08, 2011 - The qualitative tests use test strips, are
rapid (results available in <30 minutes), and are designed … The
quantitative tests use luminescence immunoassay, are slower (results available in a few
hours … test short enough to be
reasonably sure that the target condition did not change between the two
tests
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-197-fractional-exhaled-nitric-oxide.pdf
December 01, 2017 - key questions (KQ 1.b-e), studies were
quite heterogeneous in terms of design, population, control
tests
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
December 31, 2022 - We considered which tests were used
(serologic, virologic, and clinical assessment), when they were … Misclassification can occur if, for
example, the tests used to diagnose infection had poor sensitivity … Different cutoffs for the waiting period between first and second positive tests
influence the apparent … large proportion of patients in the dataset were excluded from
the analysis due to lack of serial tests … Comprehensive
characterization of COVID-19 patients with
repeatedly positive SARS-CoV-2 tests using
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mrsa-screening_research.pdf
June 01, 2013 - What are the most effective tests for MRSA screening?
5. … • What are the most effective tests for MRSA screening? … What are the most effective tests for MRSA screening?
5. … What are the most effective tests for MRSA screening?
4. … 9 35
4 What are the most effective tests for MRSA screening?